UTHR- United Therapeutics Corporation

Name: United Therapeutics Corporation Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 88 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Rothblatt Martine A	324.9K	$168.62M	-76,000
VP	Mahon Paul A	40.2K	$20.86M	-
CFO	Edgemond James	18.9K	$9.80M	-
Dir	Kurzweil Ray	17.6K	$9.12M	-
CFO	Edgemond James	11.7K	$6.05M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 30, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$524.90	$4,986,594.10	-0.5%	-	-
Jul 29, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$522.37	$4,962,487.78	-0.4%	-	-
Jul 28, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$526.73	$5,003,975.56	-0.3%	-	-
Jul 27, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$530.42	$5,038,970.75	-0.3%	-	-
Jul 24, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$531.74	$5,051,518.52	-0.4%	-	-
Jul 14, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$526.83	$5,004,908.72	-2.4%	-	-
Jul 9, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$551.13	$5,235,756.07	-2.6%	-	-
Jul 8, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$553.17	$5,255,111.50	-1.8%	-	-
Jul 6, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$548.96	$5,215,133.38	-2.7%	-	-
Jun 25, 2026	Rothblatt Martine A58	Chairperson &CEO	Sale+OE	9,500	$550.40	$5,228,772.56	-1.9%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC